Upcoming Program

Training Workshop: Biosafety and Biosecurity in Microbiological and Biomedical Research, Diagnosis, and in Clinical Care

About the Program:

This training workshop on -“Biosafety and Biosecurity in Microbiological and Biomedical Research, Diagnosis, and Clinical Care”- is to ensure safety of the individuals working in human and animal health research and diagnostic laboratories or in production facilities and to protect the environment from biohazards. The training strives to educated participants to ensure the biological safety and security of all individuals, resources, information, and biological agents. The benefit envisioned by the biosafety and biosecurity training is that it will create a solid understanding and knowledge on biosafety and biosecurity, generate working skills, and ultimately will help to motivate and apply biosafety principles and practices in research and diagnostic activities.

Program at a glance:

Day 1: Friday 22 October 2021, 16:00 20:45

Opening Ceremony

Principles and Practices of Biosafety and Biosecurity in Human Health Laboratories and Pharmaceutical Industries

Day 2: Saturday 23 October 2021, 14:30 - 18:45

Biosafety and Biosecurity in Animal Health Laboratories and Biosecurity Animal Production and Veterinary Medicine

Day 3: Sunday 24 October 2021, 14:30 – 18:00

Biological Safety Cabinet Selection, Installation and Certification and Biohazardous Waste Management

Day 4: Friday 29 October 2021, 14:30 – 18:00

Biosafety and Biosecurity Practices in Clinical Care

Day 5: Saturday 30 October 2021, 14:30 – 18:00

Biosafety and Biosecurity in High Containment Laboratories

Day 6: Sunday 31 October 2021, 14:30 – 18:00

Biosafety and Biosecurity in Biotechnology Applications

Day 7: Saturday 6 November 2021 14:30 – 18:00

Writing Standard Operating Procedure, and

Closing Sessions

This certification program is designed for research students or researchers, fellows or technicians, and faculties or industry personnel, who are working or planning to work with infectious agents, biological materials may contain infectious agents, or biohazardous materials. No previous formal training on Biosafety or Biosecurity is required to participate in this training; however, this training would be more meaningful for the biological/microbiological/medical graduates having good biochemistry, microbiology and/or molecular biology knowledge.

Register Online for October 2021 Training Workshop!

Last date of registration: 15 October, 2021

Dry run: 21 October 2021 at 19:30

========================================================================================

Special Activity

Biohazard Bags, Sharps Containers and PPE are available!

Place your requirement to biohazardmanagebd@gmail.com 

========================================================================================

About SARS-CoV

CoVs are a large family of viruses that cause illness ranging from the common cold caused by four human HCoVs that are endemic globally are HCoV-229E, HCoV-NL63, HCoV-HKU1 as well as HCoV-OC43, and more severe diseases caused by Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. CoVs are transmitted between animals and humans. Several known CoVs are circulating in animals that have not yet infected humans. 

Respiratory symptoms, fever, cough, shortness of breath, and breathing difficulties are the common signs of infection. Infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death, in more severe cases.

To prevent infection spread, regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs are the standard recommendations. Close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing must be restricted.

========================================================================================

Weblinks/Updates/Guidelines

To know the detail about MERS and SARS CoV follow the link MERS and SERS CoV. The information presented here are, collected from pathogens safety data sheet Canada, presented without any change! WHO has published its interim guidance for laboratory biosafety related to 2019-nCoV/COVID-19/SARS-CoV-2 that are available at Bangladesh Biosafety and Biosecurity Society (bdbiosafetysecurity.org).

To know the detail about Infection prevention and control during health care when SARS-CoV2 is suspected please visit: Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, Interim guidance & Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection

========================================================================================

Laboratory testing for SARS-CoV

The etiologic agent responsible for the cluster of pneumonia cases in Wuhan has been identified as a novel beta coronavirus, (in the same family as SARS-CoV and MERS-CoV) via next-generation sequencing (NGS) from cultured virus or directly from samples received from several pneumonia patients.

Electron microscopy revealed a virus with a characteristic crown morphology: a coronavirus. Working directly from sequence information, the team developed a series of genetic amplification (PCR) assays used by laboratories associated with the China CDC to detect several dozen cases as of today.

China CDC Primers and probes for detection 2019-nCoV (24 January 2020)

Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin Germany (17 January 2020)

Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by RT-PCR – Hong Kong University (23 January 2020)

PCR and sequencing protocol for 2019-nCoV - Department of Medical Sciences, Ministry of Public Health, Thailand (Updated 28 January 2020)

PCR and sequencing protocols for 2019-nCoV- National Institute of Infectious Diseases Japan (24 January 2020)

US CDC panel primer and probes– U.S. CDC, USAV – U.S. CDC, USA (28 January 2020)

• US CDC panel primer and probes– U.S. CDC, USA (28 January 2020)

News Letters 

This quarterly Newsletter is dedicated to strengthening Biosafety and Biosecurity status in Bangladesh leading to sustainable development in Health and Agriculture. Contact the "Managing Editor" for communicating information on biosafety and biosecurity and related advancement and issues to publish on this page.

করোনার ভাইরাস ছড়িয়ে পড়া এবং এই ভাইরাসের সংক্রমণ নিয়ন্ত্রণ করতে সাধারণ সচেতনতা আর আমাদের যা করতে হবে!